<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC9720004</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC9720004.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">9720004</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">9720004</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">36479018</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1002/dad2.12381</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">DAD212381</article-id></all-ids><extracted-table><table-id>dad212381-tbl-0001</table-id><table-label>TABLE 1</table-label><table-caption>Participant demographics</table-caption><table-wrap-foot/><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="dad212381-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Participant demographics</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"><italic toggle="yes">N</italic></th><th align="left" rowspan="1" colspan="1">213</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Males, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">78 (36.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Females, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">135 (63.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Age in years, Mean (SD)</td><td align="left" rowspan="1" colspan="1">64.6 (7.3)</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">APOE</italic> ε4 carriers, <italic toggle="yes">n</italic> (% of sample)</td><td align="left" rowspan="1" colspan="1">70 (32.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">CU/MCI/AD, <italic toggle="yes">n</italic></td><td align="left" rowspan="1" colspan="1">198/13/2</td></tr><tr><td align="left" rowspan="1" colspan="1">CSF biomarker cutoff groups, <italic toggle="yes">n</italic> (% of sample):</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">A+/T−, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">19 (8.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">A−/T+, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">13 (6.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">A−/T−, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">164 (77.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">A+/T+, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">17 (8.0)</td></tr></tbody></table><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Participant demographics</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left">N</th><th align="left">213</th></tr></thead><tbody><tr><td align="left">Males, n (%)</td><td align="left">78 (36.6)</td></tr><tr><td align="left">Females, n (%)</td><td align="left">135 (63.4)</td></tr><tr><td align="left">Age in years, Mean (SD)</td><td align="left">64.6 (7.3)</td></tr><tr><td align="left">APOE ε4 carriers, n (% of sample)</td><td align="left">70 (32.9)</td></tr><tr><td align="left">CU/MCI/AD, n</td><td align="left">198/13/2</td></tr><tr><td align="left">CSF biomarker cutoff groups, n (% of sample):</td><td align="left"/></tr><tr><td align="left">A+/T−, n (%)</td><td align="left">19 (8.9)</td></tr><tr><td align="left">A−/T+, n (%)</td><td align="left">13 (6.1)</td></tr><tr><td align="left">A−/T−, n (%)</td><td align="left">164 (77.0)</td></tr><tr><td align="left">A+/T+, n (%)</td><td align="left">17 (8.0)</td></tr></tbody></table></div>John Wiley &amp; Sons, Ltd.</transformed-table></extracted-table><extracted-table><table-id>dad212381-tbl-0002</table-id><table-label>TABLE 2</table-label><table-caption>Percentage of WM skeleton voxels with significant associations (positive: bold, negative: light, or none: blank) between CSF markers and diffusion parameters of WM microstructure (corrected for age, sex, and multiple comparisons across voxels, p &lt; 0.05) in 213 participants</table-caption><table-wrap-foot>Note: That the associations between each DWI‐CSF marker pair were always in the same direction across WM voxels.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="dad212381-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Percentage of WM skeleton voxels with significant associations (positive: bold, negative: light, or none: blank) between CSF markers and diffusion parameters of WM microstructure (corrected for age, sex, and multiple comparisons across voxels, <italic toggle="yes">p</italic> &lt; 0.05) in 213 participants</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">CSF Marker</th><th align="left" rowspan="1" colspan="1">FA</th><th align="left" rowspan="1" colspan="1">MD</th><th align="left" rowspan="1" colspan="1">RD</th><th align="left" rowspan="1" colspan="1">AxD</th><th align="left" rowspan="1" colspan="1">NDI</th><th align="left" rowspan="1" colspan="1">ODI</th><th align="left" rowspan="1" colspan="1">ISO</th><th align="left" rowspan="1" colspan="1">RTOP</th><th align="left" rowspan="1" colspan="1">RTAP</th><th align="left" rowspan="1" colspan="1">RTPP</th><th align="left" rowspan="1" colspan="1">MSD</th><th align="left" rowspan="1" colspan="1">NG</th><th align="left" rowspan="1" colspan="1">NG<sub>⊥</sub></th><th align="left" rowspan="1" colspan="1">NG<sub>∥</sub></th><th align="left" rowspan="1" colspan="1">QIV</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Aβ<sub>42</sub>/Aβ<sub>40</sub></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>49.0</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>70.6</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>26.3</bold></td><td align="left" rowspan="1" colspan="1"><bold>25.8</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">pTau</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.0</td><td align="left" rowspan="1" colspan="1"><bold>3.0</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">8.0</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">82.2</td><td align="left" rowspan="1" colspan="1">91.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>30.9</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">pTau/Aβ<sub>42</sub></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">84.2</td><td align="left" rowspan="1" colspan="1"><bold>10.3</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">25.0</td><td align="left" rowspan="1" colspan="1">14.2</td><td align="left" rowspan="1" colspan="1">41.7</td><td align="left" rowspan="1" colspan="1"><bold>62.1</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">NfL</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">77.4</td><td align="left" rowspan="1" colspan="1"><bold>24.7</bold></td><td align="left" rowspan="1" colspan="1"><bold>57.8</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">80.6</td><td align="left" rowspan="1" colspan="1"><bold>3.7</bold></td><td align="left" rowspan="1" colspan="1">59.0</td><td align="left" rowspan="1" colspan="1">41.7</td><td align="left" rowspan="1" colspan="1">14.0</td><td align="left" rowspan="1" colspan="1"><bold>83.1</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">α‐synuclein</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">7.6</td><td align="left" rowspan="1" colspan="1">35.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">sTREM2</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>31.7</bold></td><td align="left" rowspan="1" colspan="1"><bold>7.6</bold></td><td align="left" rowspan="1" colspan="1"><bold>10.7</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2.8</td><td align="left" rowspan="1" colspan="1">49.6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GFAP</td><td align="left" rowspan="1" colspan="1"><bold>0.53</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>60.6</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">9.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">26.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Neurogranin</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">YKL‐40</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="dad212381-tbl2-note-0001"><p><italic toggle="yes">Note</italic>: That the associations between each DWI‐CSF marker pair were always in the same direction across WM voxels.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></original-table><transformed-table>TABLE 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Percentage of WM skeleton voxels with significant associations (positive: bold, negative: light, or none: blank) between CSF markers and diffusion parameters of WM microstructure (corrected for age, sex, and multiple comparisons across voxels, p &lt; 0.05) in 213 participants</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left">CSF Marker</th><th align="left">FA</th><th align="left">MD</th><th align="left">RD</th><th align="left">AxD</th><th align="left">NDI</th><th align="left">ODI</th><th align="left">ISO</th><th align="left">RTOP</th><th align="left">RTAP</th><th align="left">RTPP</th><th align="left">MSD</th><th align="left">NG</th><th align="left">NG⊥</th><th align="left">NG∥</th><th align="left">QIV</th></tr></thead><tbody><tr><td align="left">Aβ42/Aβ40</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">49.0</td><td align="left"/><td align="left"/><td align="left">70.6</td><td align="left"/><td align="left"/><td align="left"/><td align="left">26.3</td><td align="left">25.8</td><td align="left"/><td align="left"/></tr><tr><td align="left">pTau</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">3.0</td><td align="left">3.0</td><td align="left"/><td align="left"/><td align="left"/><td align="left">8.0</td><td align="left"/><td align="left">82.2</td><td align="left">91.5</td><td align="left"/><td align="left">30.9</td></tr><tr><td align="left">pTau/Aβ42</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">84.2</td><td align="left">10.3</td><td align="left"/><td align="left"/><td align="left"/><td align="left">3.3</td><td align="left"/><td align="left">25.0</td><td align="left">14.2</td><td align="left">41.7</td><td align="left">62.1</td></tr><tr><td align="left">NfL</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">77.4</td><td align="left">24.7</td><td align="left">57.8</td><td align="left"/><td align="left"/><td align="left">80.6</td><td align="left">3.7</td><td align="left">59.0</td><td align="left">41.7</td><td align="left">14.0</td><td align="left">83.1</td></tr><tr><td align="left">α‐synuclein</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">7.6</td><td align="left">35.5</td><td align="left"/><td align="left"/></tr><tr><td align="left">sTREM2</td><td align="left"/><td align="left">31.7</td><td align="left">7.6</td><td align="left">10.7</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">2.8</td><td align="left">49.6</td><td align="left"/><td align="left"/></tr><tr><td align="left">GFAP</td><td align="left">0.53</td><td align="left"/><td align="left"/><td align="left"/><td align="left">60.6</td><td align="left"/><td align="left">9.5</td><td align="left"/><td align="left"/><td align="left"/><td align="left">26.5</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Neurogranin</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">YKL‐40</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr></tbody></table></div>Note: That the associations between each DWI‐CSF marker pair were always in the same direction across WM voxels.John Wiley &amp; Sons, Ltd.</transformed-table></extracted-table></extracted-tables-set>